Diabetes news

SGLT2 inhibitors endorsed for NHS use as monotherapies

SGLT2 inhibitors endorsed for NHS use as monotherapies

Canagliflozin, dapagliflozin and empagliflozin have...

Pictorial guide to diabetes devices now available on MIMS website

Pictorial guide to diabetes devices now available on MIMS website

GPs and MIMS subscribers can now view images and key...

Foot care reminder for canagliflozin prescribing

Foot care reminder for canagliflozin prescribing

Healthcare professionals have been reminded of the...

New advice on diabetic ketoacidosis risk with SGLT2 inhibitors

New advice on diabetic ketoacidosis risk with SGLT2 inhibitors

Measures to reduce the risk of rare diabetic ketoacidosis...

MIMS publishes summary of new NICE diabetes guidance

MIMS publishes summary of new NICE diabetes guidance

A quick-reference MIMS summary of the recently revised...

Albiglutide: new once-weekly GLP-1 receptor agonist for diabetes

Albiglutide: new once-weekly GLP-1 receptor agonist for diabetes

Eperzan (albiglutide) is indicated for the treatment...

GPs warned of potential insulin shortages

GPs warned of potential insulin shortages

Sanofi has announced a possible supply shortage of...

New for diabetes: empagliflozin/metformin fixed-dose combination

New for diabetes: empagliflozin/metformin fixed-dose combination

The SGLT2 inhibitor empagliflozin (Jardiance) is now...

First biosimilar insulin launches

First biosimilar insulin launches

Abasaglar is a new biosimilar version of the long-acting...

New high-strength insulin glargine formulation

New high-strength insulin glargine formulation

Toujeo (insulin glargine) is a 300 units/ml formulation...

Novopen 4 insulin device discontinued
SGLT2 inhibitors: risk of diabetic ketoacidosis

SGLT2 inhibitors: risk of diabetic ketoacidosis

Patients receiving SGLT2 inhibitors (canagliflozin,...

Humapen Memoir insulin pen discontinued
Higher strength Humalog insulin pen now available
JuniorSTAR insulin pen launched

JuniorSTAR insulin pen launched

NICE approval for newest SGLT2 inhibitor in diabetes

NICE approval for newest SGLT2 inhibitor in diabetes

Patients with type II diabetes will be able to get...

Ultra long-acting insulin approved for paediatric use

Ultra long-acting insulin approved for paediatric use

The once-daily basal insulin analogue Tresiba (insulin...

In Depth | Trulicity: new once-weekly treatment for type II diabetes

In Depth | Trulicity: new once-weekly treatment for type II diabetes

Trulicity (dulaglutide) is a once-weekly glucagon-like...

Bydureon available as prefilled pen

MIMS Clinics

Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Alert:
Urgent prescribing updates
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases

Promo Image

Clinical calculators

Handy calculators and conversions for primary care.